Non-adherence to lifestyle changes during pregnancy

Non-adherenceto lifestyle changes during pregnancy

Nameof Student

Signsand symptoms indicating a pregnant patient’s non-adherence to therecommended lifestyle changes related to smoking.

Suchsymptoms and signs can be predicted early enough by studying themother’s attitude towards the pregnancy (Tharpe, Farley &ampJordan, 2013). When the pregnancy is unintended, the mother is morelikely not to care about the outcome and as a result, find it hard toquit smoking . A mother who misses scheduled cessation sessions orreschedules treatment sessions is less likely to quit and suchunwillingness to adhere to the protocol can be noted during the earlystages of pregnancy. Dropping out of clinic visits is a sure sign ofnon-adherence.

Impactof non-adherence to the recommended lifestyle on the fetus and themother.

Smokingwhile pregnant lowers the amount of oxygen in the body, affectingboth the mother and the unborn child. Non-adherence to quit smokingresults into an increased heart rate, early birth (before 37 weeks),miscarriage, or a stillbirth for the patient. Both the patient andthe fetus are subjected to respiratory disorders such as asthma(Walker &amp Whittlelesea, 2012). Behavioral problems, frequentinfection, retarded mental development and sudden death of the infantalso accompany non-adherence.

Treatmentand management strategies for patients presenting with signs andsymptoms resulting from their non-adherence to stop smoking

Patientspresenting with non-adherence symptoms should be exposed topregnancy-tailored counseling sessions for enlightment. Careproviders should assess their patients’ understanding of the issueand communicate effectively to them. By consistently reminding andadvising patients against the effects of smoking to them and theunborn child, the patient’s perspective towards the habit canchange (Frandsen, Pennington &amp Abrams, 2014). Following up thepatient to track their progress, enhance adherence and to reinforcetheir cessation attempts, is primary in building trust and fosteringa healthy therapeutic relationship.

References

Tharpe,N. L., Farley, C., &amp Jordan, R. G. (2013). Clinical practiceguidelines for midwifery &amp Women’s health (4th ed.).Burlington, MA: Jones &amp Bartlett Publishers

TheAmerican College of Obstetricians and Gynecologists. (2010). Smokingcessation during pregnancy. Retrieved fromhttp://www.acog.org/Resources_And_Publications/Committee_Opinions/Committee_on_Health_Care_for_Underserved_Women/Smoking_Cessation_During_Pregnancy

Frandsen,G., Pennington, S. S., &amp Abrams, A. C. (2014). Abrams`clinical drug therapy: Rationales for nursing practice.Philadelphia: Wolters Kluwer Health/Lippincott Williams &amp Wilkins

Walker,R., &amp Whittlesea, C. (2012). Clinicalpharmacy and therapeutics.Edinburgh: Churchill Livingstone.